Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ADANI ENTERPRISES vs BALAXI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ADANI ENTERPRISES BALAXI PHARMA ADANI ENTERPRISES/
BALAXI PHARMA
 
P/E (TTM) x 91.9 -121.5 - View Chart
P/BV x 10.4 3.7 283.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ADANI ENTERPRISES   BALAXI PHARMA
EQUITY SHARE DATA
    ADANI ENTERPRISES
Mar-23
BALAXI PHARMA
Mar-23
ADANI ENTERPRISES/
BALAXI PHARMA
5-Yr Chart
Click to enlarge
High Rs4,190670 625.3%   
Low Rs1,017490 207.6%   
Sales per share (Unadj.) Rs1,201.6330.5 363.6%  
Earnings per share (Unadj.) Rs19.445.2 42.9%  
Cash flow per share (Unadj.) Rs40.746.9 86.9%  
Dividends per share (Unadj.) Rs1.200-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs289.9169.5 171.0%  
Shares outstanding (eoy) m1,140.0010.18 11,198.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.8 123.4%   
Avg P/E ratio x134.412.8 1,045.7%  
P/CF ratio (eoy) x63.912.4 516.2%  
Price / Book Value ratio x9.03.4 262.4%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m2,967,7935,905 50,255.5%   
No. of employees `000NANA-   
Total wages/salary Rs m18,773290 6,483.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,369,7783,364 40,714.7%  
Other income Rs m11,97426 45,406.1%   
Total revenues Rs m1,381,7513,391 40,751.2%   
Gross profit Rs m84,587574 14,732.5%  
Depreciation Rs m24,36118 138,969.8%   
Interest Rs m39,70014 288,306.5%   
Profit before tax Rs m32,499569 5,709.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10,410110 9,497.8%   
Profit after tax Rs m22,089460 4,805.9%  
Gross profit margin %6.217.1 36.2%  
Effective tax rate %32.019.3 166.4%   
Net profit margin %1.613.7 11.8%  
BALANCE SHEET DATA
Current assets Rs m370,2171,935 19,131.6%   
Current liabilities Rs m448,031531 84,322.5%   
Net working cap to sales %-5.741.7 -13.6%  
Current ratio x0.83.6 22.7%  
Inventory Days Days622 2,996.8%  
Debtors Days Days3567 0.6%  
Net fixed assets Rs m1,041,568462 225,652.6%   
Share capital Rs m1,140102 1,119.7%   
"Free" reserves Rs m329,3701,624 20,281.2%   
Net worth Rs m330,5101,726 19,150.8%   
Long term debt Rs m325,9009 3,745,980.5%   
Total assets Rs m1,412,7852,397 58,947.3%  
Interest coverage x1.842.3 4.3%   
Debt to equity ratio x1.00 19,560.4%  
Sales to assets ratio x1.01.4 69.1%   
Return on assets %4.419.8 22.1%  
Return on equity %6.726.6 25.1%  
Return on capital %11.033.6 32.7%  
Exports to sales %00-   
Imports to sales %32.50-   
Exports (fob) Rs m625NA-   
Imports (cif) Rs m445,499NA-   
Fx inflow Rs m625802 77.9%   
Fx outflow Rs m445,49940 1,119,062.3%   
Net fx Rs m-444,874763 -58,338.0%   
CASH FLOW
From Operations Rs m176,26561 290,147.5%  
From Investments Rs m-168,601-106 159,584.4%  
From Financial Activity Rs m-11,975255 -4,693.8%  
Net Cashflow Rs m9,701210 4,614.7%  

Share Holding

Indian Promoters % 59.0 66.9 88.3%  
Foreign collaborators % 13.6 0.0 -  
Indian inst/Mut Fund % 20.2 17.2 117.1%  
FIIs % 14.4 17.2 83.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 27.4 33.1 82.6%  
Shareholders   537,342 5,206 10,321.6%  
Pledged promoter(s) holding % 0.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ADANI ENTERPRISES With:   REDINGTON    MMTC    NOVARTIS    SIRCA PAINTS INDIA    OPTIEMUS INFRACOM    


More on Adani Enterprises vs BALAXI PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Adani Enterprises vs BALAXI PHARMA Share Price Performance

Period Adani Enterprises BALAXI PHARMA
1-Day 0.19% -0.87%
1-Month -0.88% 12.48%
1-Year 63.26% 5.64%
3-Year CAGR 38.60% -2.61%
5-Year CAGR 86.25% -1.57%

* Compound Annual Growth Rate

Here are more details on the Adani Enterprises share price and the BALAXI PHARMA share price.

Moving on to shareholding structures...

The promoters of Adani Enterprises hold a 72.6% stake in the company. In case of BALAXI PHARMA the stake stands at 66.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Adani Enterprises and the shareholding pattern of BALAXI PHARMA.

Finally, a word on dividends...

In the most recent financial year, Adani Enterprises paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of 6.2%.

BALAXI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Adani Enterprises, and the dividend history of BALAXI PHARMA.



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.